Biomimetic nanosystems based on cell membranes (BNCMs) for cancer immunotherapy DOI Creative Commons
Yixi Wang,

Xianzhou Huang,

Qinjie Wu

и другие.

MedComm – Biomaterials and Applications, Год журнала: 2024, Номер 3(4)

Опубликована: Дек. 1, 2024

Abstract With the development of nanosystems, they are gradually utilized to ameliorate diverse cancer therapies. Specifically for immunotherapy, most nanosystems elaborately designed initiate self‐sustaining “cancer immunity cycle (CIC)” elicit immune response. However, owing highly complex circulatory environment, may face issues like nonspecific nanoparticle uptake and rapid clearance, leaving enormous room advancement. For employing biomimetic design in based on cell membranes (BNCMs) inherit various functional molecules from source cells, permitting precise tumor targeting, enhancing blood circulation, conferring more desired functionality a robust To take full advantage BNCMs, understanding their functions immunotherapy is essential. In this review, unique properties BNCMs derived cells main preparation strategies introduced. Subsequently, recent advances improving discussed aspects roles particular stages CIC, working mechanisms outer highlighted. Finally, along with analysis existing bottlenecks clinical translation, some suggestions future put forward.

Язык: Английский

Biomimetic functionalized metal organic frameworks as multifunctional agents: Paving the way for cancer vaccine advances DOI Creative Commons

Bushra Tousian,

Alireza Khosravi,

Mohammad Hadi Ghasemi

и другие.

Materials Today Bio, Год журнала: 2024, Номер 27, С. 101134 - 101134

Опубликована: Июнь 20, 2024

Biomimetic functionalized metal-organic frameworks (Fn-MOFs) represent a cutting-edge approach in the realm of cancer vaccines. These multifunctional agents, inspired by biological systems, offer unprecedented opportunities for development next-generation The vast surface area, tunable pore size, and diverse chemistry MOFs provide versatile scaffold encapsulation protection antigenic components, crucial vaccine stability delivery. This work delves into innovative design application Fn-MOFs, highlighting their role as carriers immune enhancement potential to revolutionize By mimicking natural processes, with ability be myriad chemical entities, exhibit superior biocompatibility stimuli-responsive behavior facilitate targeted delivery tumor sites. review encapsulates latest advancements Fn-MOF technology, from synthesis modification integration combination therapies. It underscores significance biomimetic approaches overcoming current challenges development, such antigen evasion. leveraging nature this paves way strategies vaccines, aiming induce potent long-lasting responses against malignancies.

Язык: Английский

Процитировано

4

Copper-Consuming Nanoplatform for Alleviating Hypoxia and Overcoming Resistance to Sonodynamic Therapy of Breast Cancer DOI

Ze Song,

Xi Deng,

Liping Jiang

и другие.

ACS Applied Materials & Interfaces, Год журнала: 2024, Номер 16(43), С. 58357 - 58369

Опубликована: Окт. 16, 2024

Sonodynamic therapy (SDT) is a promising treatment modality for breast cancer; however, its effectiveness often impeded by the hypoxic tumor microenvironment owing to an insufficient oxygen supply in solid tumors. To overcome this challenge, we elaborately developed 4T1 tumor-targeted multifunctional nanoagent integrating both dendrimer-structured copper chelating agents and organic sonosensitizers (IR820) into biotin-modified nanoliposome via microfluidic-assisted self-assembly. In particular, aforementioned agent was constructed introducing multiple xanthate groups dendrimer polymer, which showed significant selectivity consumption of intracellular levels. Based on this, nanoliposome-based therapeutic not only disrupted activity mitochondrial complex IV directly inhibit cell proliferation but also suppressed resistance SDT inhibition cellular respiration. Both vitro vivo studies confirmed that designed nanoagents exhibit synergistic effect IR820-mediated SDT. Taken together, approach establishes proof-of-concept construction copper-ion-modulated nanomedicine significantly enhance efficiency oxygen-dependent cancer treatments.

Язык: Английский

Процитировано

3

Direct hydroxylation of toluene catalyzed by MOF-199 modified with PG 8 using H2O2 as oxidant DOI
Tianyong Zhang,

Kexin Jia,

Shuang Jiang

и другие.

Materials Research Bulletin, Год журнала: 2024, Номер 178, С. 112850 - 112850

Опубликована: Апрель 28, 2024

Язык: Английский

Процитировано

1

Metal‐organic frameworks‐based nanomedicines to promote cancer immunotherapy: Recent advances and future directions DOI Creative Commons
Chenqian Feng, Xiaoyan Liang, Rangrang Fan

и другие.

MedComm – Biomaterials and Applications, Год журнала: 2024, Номер 3(4)

Опубликована: Окт. 19, 2024

Abstract Cancer immunotherapy uses the body's immune system to fight tumors by restoring natural antitumor responses. Metal‐organic frameworks (MOFs), characterized their unique crystalline porous structures formed from metal ions linked organic ligands, offer a promising solution. Recent studies have unveiled potential of MOFs in cancer immunotherapy. The exceptional porosity and surface area, coupled with extraordinary thermal chemical stability, bring significant advantages for efficient drug loading delivery immunotherapeutic agents. adaptability further enhances controlled release drugs within target cells increases tumor sensitivity other therapies such as photodynamic, photothermal, radiotherapy. This multifunctional carrier contributes modulating microenvironment reactivating immunity, providing comprehensive strategy treatment. In this review, we summarize applications checkpoint blockade, immunomodulator delivery, vaccine discuss existing challenges use discussion aims insights developing better treatments enhancing efficacy

Язык: Английский

Процитировано

0

FeS2@COF based nanocarrier for photothermal-enhanced chemodynamic/thermodynamic tumor therapy and immunotherapy via reprograming tumor-associated macrophages DOI Creative Commons
Xiangtian Deng,

Renliang Zhao,

YunFeng Tang

и другие.

Journal of Nanobiotechnology, Год журнала: 2024, Номер 22(1)

Опубликована: Ноя. 15, 2024

Developing high-performance nanomedicines to enhance antitumor efficacy remains a hot point in the field of biomedicine. In this study, we designed versatile nanocomposite (FeS₂@COF-HA/AIPH) integrating covalent organic frameworks (COF) functionalized with pyrite (FeS₂) for synergistic photothermal (PTT), chemodynamic (CDT), thermodynamic (TDT) therapies, and immunotherapy. The superior effects catalytic capabilities FeS₂@COF enabled minimally invasive PTT/CDT combination. nanoplatform, its mesoporous structure, also served as drug delivery system, encapsulating thermos-decomposable initiator AIPH. hyaluronic acid (HA) coating not only improved tumor-targeting efficiency but prevented nonspecific AIPH release. Under near-infrared (NIR) irradiation, localized hyperthermia triggered decomposition, generating toxic alkyl radicals (•R) TDT, further enhancing CDT efficiency. combination PTT, CDT, immunotherapy led potent minimal systemic toxicity, both vitro vivo. Notably, nanoplatform effectively reprogrammed tumor-associated macrophages (TAMs) from an M2 M1 phenotype, boosting immunity. This multifunctional platform thus offers promising strategy integrated immune activation tumor therapy.

Язык: Английский

Процитировано

0

Disrupting calcium homeostasis and glycometabolism in engineered lipid-based pharmaceuticals propel cancer immunogenic death DOI Creative Commons

Qiuxia Peng,

Xiao‐Long Li, Chao Fang

и другие.

Acta Pharmaceutica Sinica B, Год журнала: 2024, Номер unknown

Опубликована: Дек. 1, 2024

Язык: Английский

Процитировано

0

Biomimetic nanosystems based on cell membranes (BNCMs) for cancer immunotherapy DOI Creative Commons
Yixi Wang,

Xianzhou Huang,

Qinjie Wu

и другие.

MedComm – Biomaterials and Applications, Год журнала: 2024, Номер 3(4)

Опубликована: Дек. 1, 2024

Abstract With the development of nanosystems, they are gradually utilized to ameliorate diverse cancer therapies. Specifically for immunotherapy, most nanosystems elaborately designed initiate self‐sustaining “cancer immunity cycle (CIC)” elicit immune response. However, owing highly complex circulatory environment, may face issues like nonspecific nanoparticle uptake and rapid clearance, leaving enormous room advancement. For employing biomimetic design in based on cell membranes (BNCMs) inherit various functional molecules from source cells, permitting precise tumor targeting, enhancing blood circulation, conferring more desired functionality a robust To take full advantage BNCMs, understanding their functions immunotherapy is essential. In this review, unique properties BNCMs derived cells main preparation strategies introduced. Subsequently, recent advances improving discussed aspects roles particular stages CIC, working mechanisms outer highlighted. Finally, along with analysis existing bottlenecks clinical translation, some suggestions future put forward.

Язык: Английский

Процитировано

0